RobertJFontanaMD
Gastroenterology • Ann Arbor, MIHepatology & Liver Transplantation
Professor, Internal Medicine, University of Michigan Medical School
Dr. Fontana is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
# 3
Ann Arbor, MI 48109Phone+1 734-647-5944
Education & Training
University of MichiganFellowship, Gastroenterology, 1992 - 1994
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1988 - 1991
University of Michigan Medical SchoolClass of 1988
Certifications & Licensure
MI State Medical License 1993 - 2027
IL State Medical License 1988 - 1993- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- DILIN - Prospective Study Start of enrollment: 2004 Sep 01
- Drug-Induced Liver Injury (DILI) Network Retrospective Start of enrollment: 2004 Sep 01
- A Multi-Center Trial to Study Acute Liver Failure in Adults Start of enrollment: 1998 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 129 citationsRenal outcomes after liver transplantation in the model for end-stage liver disease era.Pratima Sharma, Kathy Welch, Richard Eikstadt, Jorge A. Marrero, Robert J. Fontana
Liver Transplantation. 2009-09-01 - 630 citationsLedipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver DiseaseMichael Charlton, Gregory T. Everson, Steven L. Flamm, Princy Kumar, Charles Landis
Gastroenterology. 2015-09-01 - 3228 citationsA simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis CChun-Tao Wai, Joel K. Greenson, Robert J. Fontana, John D. Kalbfleisch, Jorge A. Marrero
Hepatology. 2003-08-01
Press Mentions
Did FDA Regulation Reduce High Rates of Opioid-Acetaminophen Overdoses?March 28th, 2023- Study May Accelerate Identifying Patients Who Need Liver TransplantsMarch 27th, 2023
- Eliminating Hepatitis C for Nearly 200,000 in MichiganJuly 28th, 2020
- Join now to see all
Grant Support
- Michigan Hepatotoxicity Clinical Research NetworkNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2011
- A Multi-Center, Longitudinal Study Of Drug-And Cam-Induced Liver InjuryNational Center For Research Resources2005–2007
- Idiosyncratic Liver Injury Associated With Drugs Iliad: A Retrospective StudyNational Center For Research Resources2005–2006
- Interferon A2B VS Iron Reduction And Interferon A2B For Therapy Of Hepatitis CNational Center For Research Resources1997–2000
- Caffeine As Metabolic Probe To Predict Oral Clearance Of Tacrine In Alzheimer'SNational Center For Research Resources1997
- Interferon A2B Therapy For Chronic Viral HepatitisNational Center For Research Resources1996
- Caffeine To Predict Oral Clearance Of Tacrine In Alzheimers Disease PatientsNational Center For Research Resources1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
